pöschl et al., suppl. material supplementary material: suppl. figure 1: related to figure 1....

14
Pöschl et al., Suppl. Mater Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples. Suppl. Figure 2: Related to Figure 1. The top 25 upregulated genes per human medulloblastoma subgroup out of the differentially expressed genes used for comparative analyses of human and murine data. Suppl. Figure 3: Related to Figure 1. Mouse Wnt Medulloblastomas model well human WNT medulloblastomas, independent of TP53 mutation status. Suppl. Figure 4: Related to Figure 2. Human SHH-medulloblastomas form a „infant“ and “adult“ cluster, but no distinct “childhood“ cluster. Suppl. Figure 5: Related to Figure 2. Validation of significantly differentially expressed genes between infant and adult human SHH-medulloblastomas, that were used for analysis. Suppl. Figure 6: Related to Figure 2. Heatmap showing 287 similarly expressed genes of adult human SHH medulloblastoma and murine Shh medulloblastoma mouse models Suppl. Table 1: Related to Figure 1. Raw AGDEX values and Perm P values shown in Figure 1A. Suppl. Table 2: Related to Figure 2. Raw AGDEX values and Perm P values shown in Figure 2A. Suppl. Table 3: Related to Figure 2 and Supplementary Figure 6. List of the 287 similarly expressed genes of adult human SHH medulloblastoma and murine Shh medulloblastoma mouse models.

Upload: neal-bond

Post on 31-Dec-2015

214 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

Pöschl et al., Suppl. Material

Supplementary Material:

Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human

medulloblastoma samples.

Suppl. Figure 2: Related to Figure 1. The top 25 upregulated genes per human

medulloblastoma subgroup out of the differentially expressed genes used for comparative analyses of human and murine data.

Suppl. Figure 3: Related to Figure 1. Mouse Wnt Medulloblastomas model well

human WNT medulloblastomas, independent of TP53 mutation status.

Suppl. Figure 4: Related to Figure 2. Human SHH-medulloblastomas form a

„infant“ and “adult“ cluster, but no distinct “childhood“ cluster.

Suppl. Figure 5: Related to Figure 2. Validation of significantly differentially

expressed genes between infant and adult human SHH-medulloblastomas, that were used for analysis.

Suppl. Figure 6: Related to Figure 2.Heatmap showing 287 similarly expressed

genes of adult human SHH medulloblastoma and murine Shh medulloblastoma mouse

models

Suppl. Table 1: Related to Figure 1. Raw AGDEX values and Perm P values

shown in Figure 1A.

Suppl. Table 2: Related to Figure 2. Raw AGDEX values and Perm P values

shown in Figure 2A.

Suppl. Table 3: Related to Figure 2 and Supplementary Figure 6. List of the 287 similarly expressed genes of

adult human SHH medulloblastoma and murine Shh medulloblastoma mouse models.

Page 2: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

0 100 200 3000

50

100WNTSHHGroup 3Group 4

Time [months]

Ove

rall

surv

ival

[%

]

Supplementary Figure 1: Epidemiological and clinical data of the 423 analyzed human medulloblastoma samples.

Pöschl et al., Suppl. Figure 1

Molecular subgroup n [% of all patients] 53 [12.53] 112 [26.48] 94 [22.22] 164 [38.77]

Agegroup n % of subgroup n % of subgroup n % of subgroup n % of subgroupInfant (≤ 3 years) 0 0 29 25.89 25 26.6 8 4.88

Child (> 3 < 16 years) 44 83.02 27 24.11 63 67.02 131 79.88

Adult (≥ 16 years) 9 16.98 54 48.21 3 3.19 22 13.41Not available 2 1.79 3 3.19 3 1.83

Gender n % of subgroup n % of subgroup n % of subgroup n % of subgroupFemale 28 52.83 53 47.32 28 29.79 48 29.27Male 25 47.17 59 52.68 66 70.21 116 70.73

M stage n % of subgroup n % of subgroup n % of subgroup n % of subgroupM - 40 75.47 77 68.75 57 60.64 86 52.44

M + 5 9.43 14 12.5 31 32.98 60 36.59Not available 8 15.09 21 18.75 6 6.38 18 10.98

Histology n % of subgroup n % of subgroup n % of subgroup n % of subgroupClassic 49 92.45 38 33.93 59 62.77 123 75

Desmoplastic 0 0 42 37.5 5 5.34 9 5.49Extensively nodular 0 0 3 2.68 0 0 0 0Large cell/ anaplastic 4 7.55 16 14.29 19 20.21 18 10.98

Medullomyoblastoma 0 0 0 0 3 3.2 0 0Not available 0 0 13 11.61 8 8.51 14 8.54

10 year survival rate

WNT SHH Group 3 Group 4

97.8% 61.8% 43.5% 67.7%

Page 3: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

WNT SHH Group 3 Group 4

Supplementary Figure 2: Heatmap showing the top 25 upregulated genes per human medulloblastoma subgroup. High expression is shown in red, low expression is shown in blue.

Pöschl et al., Suppl. Figure 2

Page 4: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

data not available

TP53

TP53 mutated (n=4)TP53 WT (n=30)

Histology

Classic (n=34)

Gender

Female (n=20)Male (n=14)

Age group

Child (n=27)Adult (n=7)

Status

Alive (n=31)Dead (n=2)

Supplementary Figure 3A: Non-hierarchical average linkage clustering (20% variance filter) of 34 human WNT tumors with known TP53 mutation status. The four TP53 mutated WNT tumors did not cluster together.

TP53Status

HistologyGender

Age group

Pöschl et al., Suppl. Figure 3

Page 5: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

Age group:

Infant (≤ 3 years; n=29) Child (> 3 years < 16 years; n=27) Adult (≥ 16 years; n=54)

Supplementary Figure 4: Based on gene expression, SHH childhood medulloblastoma cases do not form a distinct cluster. Hierarchical clustering based on significantly differentially expressed genes using an “infant“, “childhood“ and “adult“ group distinguished an “infant“ and “adult“ cluster, but no distinct “childhood“ cluster. Instead childhood tumors clustered variably to the “infant“ or “adult“ SHH subgroup, with the majority been found in the „adult“ subgroup.

Pöschl et al., Suppl. Figure 4

Page 6: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

Northcott dataset

200 (out of 332)

Current dataset

705101

Age group

Infant (n=29)

Adult (n=54)

-2 0 +2

Supplementary Figure 5: 705 genes were found to be significantly differentially expressed between infantile and adult human SHH medulloblastomas in the current dataset (out of 10333 orthologue genes present on all examined platforms). The Venn diagramm shows the overlap of significant genes with the Northcott study (Northcott et al. 2011a). The Northcott study identified 332 significant differentially expressed genes – of these 200 were also present in our current dataset. 101 genes were found to be differentially expressed in both studies. Expression of these 101 genes in our dataset is displayed in the heatmap.

Pöschl et al., Suppl. Figure 5

Page 7: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

-2 0 +1.5

SHH infant (n=29)

SHH adult (n=54)

Mouse modelsn=64

Supplementary Figure 6: Heatmap showing 287 signifcant differentially expressed genes when comparing human infant SHH medulloblastoma to human adult medulloblastoma and murine medulloblastoma models. Details on the genes can be found in table S3.

Pöschl et al., Suppl. Figure 6

Page 8: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

Genotype WNT PERM P SHH PERM P Group 3 PERM P Group 4 PERM P

Blbp-cre::Ctnnb1(ex3)Fl/+ Trp53Fl/Fl (n=6) 0.3009 0.0058 0.2339 0.0284 0.2275 0.0155 0.0569 0.5280

Ptch1+/- (n=12) 0.3134 0.0359 0.4535 0.0078 0.3524 0.0409 0.1771 0.2049

Math1-creERT2::Ptch1Fl/Fl (n=4) 0.2416 0.0743 0.3717 0.0175 0.2869 0.0360 0.1489 0.2433

Nestin-creERT2::Ptch1Fl/Fl (n=4) 0.2729 0.0377 0.4057 0.0092 0.3104 0.0085 0.1776 0.1119

Ptch1+/-Trp53-/- (n=3) 0.1759 0.0059 0.2101 0.0068 0.2019 0.0015 0.1068 0.0891

Ptch1+/-Cdkn2C -/- (n=8) 0.2680 0.0364 0.4083 0.0072 0.3248 0.0083 0.2261 0.0506

Tlx3-cre:: SmoM2Fl/+ (n=3) 0.1648 0.1195 0.3152 0.0100 0.2399 0.0364 0.2103 0.0678

Olig2-tva-cre:: SmoM2Fl/+ (n=7) 0.2506 0.0855 0.3763 0.0139 0.3001 0.0728 0.1740 0.2205

Math1-cre: :SmoM2Fl/+ (n=3) CB 0.1959 0.1026 0.3652 0.0175 0.2338 0.1199 0.1407 0.2863

Math1-cre: :SmoM2Fl/+ (n=3) CN 0.2314 0.0503 0.3858 0.0124 0.2594 0.0629 0.1595 0.1984

hGFAP-cre: :SmoM2Fl/+ (n=3) CB 0.1862 0.0826 0.3490 0.0115 0.2096 0.1648 0.1235 0.2963

hGFAP-cre: :SmoM2Fl/+ (n=3) CN 0.2396 0.0622 0.3946 0.0129 0.2623 0.0927 0.1432 0.2671

Nestin-cre::Trp53Fl/Fl Cdkn2C-/- (n=8) 0.3143 0.0783 0.4542 0.0121 0.3597 0.0927 0.1457 0.3341

Sufu+/-Trp53-/- (n=3) 0.2213 0.0275 0.2901 0.0067 0.2446 0.0253 0.0678 0.4087

MycDNTrp53 (Prom1+ Lin- stem cells) (n=5) 0.3514 0.0221 0.4557 0.0049 0.4025 0.0231 0.1632 0.2364

MycDNTrp53 (Prom1+ Lin+ progenitors) (n=5) 0.3546 0.0208 0.4582 0.0052 0.4142 0.0177 0.1652 0.2210

Cdkn2c-/-Trp53-/-, mMyc (n=14) 0.3580 0.0538 0.4711 0.0227 0.4022 0.1241 0.0963 0.5570

Cdkn2c-/-Trp53-/-,hMyc (n=3) 0.3621 0.0369 0.4638 0.0159 0.4149 0.0835 0.1156 0.4567

Cdkn2c-/-Trp53-/-, MycN (n=11) 0.3731 0.0452 0.4965 0.0148 0.4031 0.1017 0.0983 0.5329

Glt1-tTA::TRE-MYCN/Luc (n=32) 0.3568 0.0071 0.3531 0.0012 0.4361 0.0002 0.2554 0.0172

Supplementary Table 1: Raw AGDEX values and Perm P values when comparing different murine medulloblastoma models to the four subgroups of medulloblastoma. The best match for each model is highlighted in orange.

Pöschl et al., Suppl. Table 1

Page 9: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

GenotypeTumor

localisation INFANT PERM P ADULT PERM P

Ptch1+/- (n=12) CB 0.1985 0.4509 0.3591 0.0156

Math1-creERT2::Ptch1Fl/Fl (n=4) CB 0.2280 0.4308 0.3066 0.0371

Nestin-creERT2::Ptch1Fl/Fl (n=4) CB 0.2378 0.3719 0.2929 0.0379

Ptch1+/-Trp53-/- (n=3) CB 0.1511 0.4311 0.3427 0.0057

Ptch1+/-Cdkn2C -/- (n=8) CB 0.1776 0.5288 0.2752 0.0775

Tlx3-cre:: SmoM2Fl/+ (n=3) CB 0.1972 0.3754 0.1968 0.0559

Olig2-tva-cre:: SmoM2Fl/+ (n=7) CB 0.1607 0.4976 0.3242 0.0150

Math1-cre: :SmoM2Fl/+ (n=3) CB 0.1461 0.5995 0.3049 0.0215

Math1-cre: :SmoM2Fl/+ (n=3) CN 0.1424 0.6068 0.3511 0.0148

hGFAP-cre: :SmoM2Fl/+ (n=3) CB 0.1151 0.6557 0.2777 0.0343

hGFAP-cre: :SmoM2Fl/+ (n=3) CN 0.1370 0.6111 0.3176 0.0234

Nestin-cre::Trp53Fl/Fl Cdkn2C-/- (n=8) CB 0.2148 0.4406 0.3474 0.0224

Sufu+/-Trp53-/- (n=3) CB 0.2144 0.3244 0.3398 0.0101

Supplementary Table 2: Raw AGDEX values and Perm P values when comparing different murine Shh medulloblastoma models to infantile or adult human SHH medulloblastoma cases. Best matches of each model are highlighted in orange.

Pöschl et al., Suppl. Table 2

Page 10: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

Pöschl et al., Suppl. Table 3High in human infant SHH Tumors

 

MEAN ADULT and MOUSE

TumorsSD Adult and

Mouse TumorsMean Infant

TumorsSD Infant Tumors

adjusted p-value FDR

ACTA1 -0,2736967 0,40240562 0,0915157 0,23518874 8,84E-06 1,31E-07ADD3 -0,3986583 0,68905705 0,840792 1,3394148 0,01567845 1,01E-04

AMPD3 -0,5510598 0,4342057 0,2113985 0,7382354 0,00359565 2,55E-05AMPH -0,4067815 0,58926404 0,5825517 1,1056875 0,0231441 1,45E-04ANK3 -0,2285457 0,7543664 1,8847224 1,2302096 1,98E-07 4,17E-09

APBB1 -0,5611082 0,43113378 0,6217667 1,1803654 0,0050552 3,44E-05APLP2 -0,6795695 0,48893243 0,3736917 0,8985004 4,46E-04 3,91E-06

ARHGAP44 -0,711981 0,29055968 -0,026718 0,79870623 0,03665173 2,22E-04ARNTL -0,810629 0,41836005 -0,2718194 0,56255317 0,01189624 7,81E-05

ASPHD2 -0,1134203 0,7686489 0,7413253 0,9500732 0,02797623 1,73E-04ATP5B -0,4874611 0,6474947 0,7393577 0,880387 1,97E-05 2,63E-07

ATP6V1G2 -0,5616174 0,34636083 0,8560063 1,4997127 0,01088189 7,18E-05BAIAP2 -0,5723038 0,3337072 0,03755 0,664901 0,01719819 1,10E-04

C14ORF169 -0,6777008 0,9619623 0,3167307 0,57554734 3,69E-07 7,49E-09C15ORF38-

AP3S2,AP3S2-0,8657904 0,5819554 -0,2318643 0,6908973 0,02257109 1,42E-04

C1QTNF4 -0,732315 0,25896174 -0,4156726 0,34892857 0,02396127 1,50E-04C21ORF59 -0,3458999 0,73729384 0,9020283 1,0727334 5,69E-04 4,90E-06

C4ORF32 -0,6650406 0,4224659 0,1392156 0,73967427 0,00160183 1,23E-05CADPS2 -0,4884835 0,48272508 1,0444686 1,4119722 0,00155643 1,20E-05CAMK4 -0,3186014 0,4471958 0,667687 0,9503742 0,00296404 2,13E-05CASQ2 -0,4050122 0,21455474 -0,1473773 0,14752753 1,34E-07 2,86E-09CBLN1 -0,3715423 0,282928 1,776182 1,6063838 4,85E-05 5,59E-07

CCDC106 -0,6514843 0,7035532 0,1099939 0,8432816 0,02731438 1,70E-04CCDC92 -0,6008607 0,6214308 0,7013466 1,450703 0,02189356 1,38E-04

CD200 -0,5056658 0,53921175 -0,0267494 0,5454667 0,04691149 2,80E-04CEP85 -0,538823 0,68906033 0,2920238 0,96610135 0,0428549 2,57E-04

CKMT1B,CKMT1A -0,6224688 0,34742752 0,1377923 0,8769979 0,03164208 1,93E-04CLSTN3 -0,5952044 0,3632332 0,0504066 0,7082706 0,01892104 1,20E-04

CORO1A -0,5336767 0,4464921 0,7978107 1,3243732 0,00469368 3,23E-05CPEB2 -0,7194768 0,45191312 0,1469895 0,65161407 5,07E-05 5,80E-07CPNE8 -0,4476648 0,58020645 0,6779916 0,89813226 1,55E-04 1,54E-06CYFIP2 -0,917551 0,3901158 -0,043476 0,73000425 3,03E-04 2,76E-06

ECHDC2 -0,4826384 0,66599435 1,0551793 1,2127678 1,14E-04 1,21E-06EFNB2 -0,3458508 0,8008046 1,0487882 1,1249865 1,77E-04 1,74E-06EMCN -0,424006 0,665607 1,2962767 1,6768299 0,00347934 2,49E-05

EPHA7 -0,4174543 0,44034973 -0,2080296 0,09831297 0,00285097 2,08E-05FAM19A5 -0,4528866 0,73674846 2,0459554 1,2566425 7,53E-09 3,36E-10

FAM32A -0,0111569 0,95822155 0,816252 0,8409857 0,01390718 9,05E-05FCGRT -0,0725804 0,77054715 1,512644 1,5657283 0,00440052 3,06E-05

FEZ1 -0,4137424 0,5256489 1,58211 1,4469427 2,80E-05 3,52E-07FGF19 -0,294138 0,61156964 1,206404 1,6895546 0,02457635 1,53E-04FOLR2 0,251809 0,8689384 1,9020073 1,6196111 0,00399639 2,82E-05FRMD6 -0,317896 0,5213716 0,657405 0,73091483 4,38E-05 5,17E-07

GALNT12 -0,3493126 0,4837105 0,301852 0,5663032 7,73E-04 6,47E-06GAS6 -0,6129618 0,42372066 0,0895829 0,46331364 2,87E-06 4,78E-08

GFPT2 -0,4169517 0,5699038 0,1298797 0,60458165 0,03042219 1,87E-04GFRA2 -0,3594359 0,44081858 0,6050958 1,1089619 0,03051798 1,87E-04GNA14 -0,269141 0,64814085 0,9480154 1,2687906 0,00967899 6,41E-05

GOT1 -0,6666146 0,37000605 0,7237064 1,5585674 0,02256819 1,42E-04GPHN -0,5273474 0,6368207 0,314085 0,6827042 2,41E-04 2,26E-06

GPI -0,7036107 0,54594487 0,3179387 1,0198526 0,00504837 3,45E-05HECW1 -0,5893436 0,29053724 0,398977 0,8163084 2,79E-04 2,60E-06HMOX2 -0,7327574 0,4980786 0,275969 1,0215478 0,00618303 4,16E-05JARID2 0,091192 0,83122766 0,955925 0,7926702 0,0023733 1,75E-05

KAZN -0,4838162 0,40413776 0,0188276 0,5786221 0,03899058 2,36E-04KCNJ3 -0,5313013 0,40783623 0,646928 1,0717127 0,00120552 9,60E-06KCNK1 -0,3665393 0,43104228 0,297203 0,6800656 0,00820862 5,48E-05

Page 11: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

KIAA1324L 0,0676648 0,9981148 1,1758844 1,0374626 0,00296822 2,14E-05KIF1B -0,7764533 0,4827391 -0,1885803 0,549708 0,00255587 1,87E-05KIF3C -0,664698 0,4528029 0,5800008 1,2612157 0,00619578 4,15E-05KLC1 -0,5468903 0,5793387 0,748115 1,0853808 3,21E-04 2,87E-06LHX8 -0,2660545 0,68339926 1,2022597 1,356885 0,00167428 1,28E-05

LIMK2 -0,5943137 0,6228112 0,9412426 1,0448354 6,02E-06 9,40E-08LNX1 -0,465056 0,5787848 0,4318597 0,6621536 3,35E-05 4,18E-07

LPHN1 -0,5410462 0,39656642 -0,2379625 0,24256623 9,17E-04 7,53E-06LURAP1L -0,3093317 0,616717 1,2649185 0,83099794 1,71E-08 6,11E-10

LYPLA2 -0,4838305 0,7399838 0,1213743 0,5470517 0,00352665 2,52E-05MAPK8IP2 -0,5336943 0,49410248 0,0362324 0,50918424 0,00142994 1,13E-05

MAPK9 -0,329942 0,63446486 1,1104557 1,0063814 1,15E-05 1,63E-07MCTP1 -0,466345 0,4392676 0,5082528 1,0660535 0,01705517 1,09E-04

MPG -0,23558 1,1221805 1,8027818 1,4923702 2,70E-05 3,43E-07MREG -0,4121273 0,40530333 0,9126195 0,7527454 1,19E-07 2,70E-09MSRA -0,3251927 0,6705541 1,964723 1,1694646 1,05E-08 4,52E-10

MTFP1 -0,7826174 0,4498654 0,019879 0,64602846 1,83E-04 1,78E-06MTUS2 -0,5276096 0,389134 0,280437 0,75469774 0,00200777 1,50E-05

NAB2 -0,3481763 0,76936394 0,5228838 0,8567274 0,0058251 3,93E-05NCDN -0,6260417 0,29826325 -0,2350343 0,45083514 0,03723336 2,26E-04NEFL -0,5429206 0,28257912 -0,079837 0,269144 1,24E-07 2,77E-09NEFM -0,601053 0,24664934 -0,101582 0,33119467 3,81E-06 6,17E-08

NEUROD1 -0,3897462 0,8010917 1,239071 0,6385459 3,01E-13 5,02E-14NRSN1 -0,5791534 0,28199756 1,696933 1,4136827 1,40E-06 2,50E-08OPLAH -0,4595209 0,54160625 0,7647645 0,98544586 1,64E-04 1,63E-06PARM1 -0,561963 0,29335842 1,0755407 1,6686709 0,0062575 4,19E-05PDE1A 0,0060667 0,8034042 1,772167 1,8814553 0,01236653 8,08E-05

PDLIM1 0,0440392 0,76221764 0,848949 0,90552276 0,03332815 2,03E-04PDRG1 -0,0141821 0,9328816 1,690243 1,3890612 2,14E-04 2,03E-06

PELI2 0,2971584 0,8203451 2,2108323 1,2810482 4,86E-06 7,67E-08PHF20L1 0,0265927 0,87338585 2,2388226 1,9816772 0,00104408 8,53E-06PHYHIP -0,4811795 0,34839746 0,1275908 0,7137319 0,04021305 2,42E-04

PIGS -0,7857006 0,546718 -0,2474285 0,5909669 0,02786803 1,73E-04PKNOX2 -0,5035165 0,47361904 0,2723562 0,5461753 1,36E-05 1,89E-07

PLCB4 -0,2250915 0,48047394 1,199794 1,0307131 2,20E-05 2,87E-07PLK3 0,2149073 1,0056143 1,932799 1,6988721 0,00490319 3,36E-05POLB -0,0305873 0,86776924 1,384233 1,3096446 0,00179864 1,37E-05

PORCN -0,6983927 0,4565519 0,27228 0,8507489 6,93E-04 5,88E-06PPFIA3 -0,6428908 0,5045011 -0,0904475 0,61259514 0,0279556 1,72E-04PPP5C -0,7080577 0,44538105 0,165045 0,9334911 0,01292741 8,43E-05

PRKACB -0,5425087 0,50499827 0,4533283 0,99355614 0,00516126 3,50E-05PYGB -0,5423337 0,57642126 0,751398 1,0356414 1,51E-04 1,52E-06

RGS10 -0,3209165 0,7441539 1,4774944 1,3027033 2,41E-05 3,12E-07RHBDF1 -0,1925004 0,66763437 1,8359515 1,6502787 1,99E-04 1,91E-06RNASE1 -0,1858564 0,55607027 1,186209 1,5394343 0,02355307 1,47E-04ROBO1 0,509507 0,8565598 1,795602 1,0970726 5,29E-04 4,60E-06ROGDI -0,7804328 0,2900936 -0,387233 0,45719376 0,04102953 2,47E-04RPP25 -0,6690362 0,4288585 -0,140358 0,4847798 0,00190542 1,44E-05

RPS6KL1 -0,9170204 0,5666589 -0,013362 0,73695856 2,28E-04 2,15E-06RUSC1 -0,2462419 0,69223845 1,1333696 1,0263491 3,91E-05 4,78E-07

RYR2 -0,454788 0,4530526 0,4303975 1,037797 0,03991968 2,41E-04SDHA -0,713013 0,5599515 0,3531556 0,76818657 2,09E-05 2,76E-07

SEPT6 -0,7200754 0,39743847 1,076147 1,6961476 0,00226349 1,68E-05SERPINI1 -0,7030228 0,35907117 0,0997056 0,9537434 0,04580552 2,74E-04

SESN1 -0,435666 0,7455516 0,8936836 1,3014187 0,00411837 2,90E-05SGIP1 -0,56837 0,32829472 -0,2615173 0,34838316 0,04170696 2,50E-04

SLC17A5 -0,2659822 0,6200616 0,5158085 0,83521056 0,01610521 1,03E-04SLC22A15 -0,1662992 0,60187596 1,708103 1,6899402 0,00114985 9,28E-06

SLC35F3 -0,7217239 0,40244249 0,7692608 1,0323119 9,83E-06 1,44E-07SLC38A1 -0,5503948 0,8365302 0,1540708 0,64937586 0,0041854 2,93E-05SLC8A2 -0,281969 0,5725372 0,9984013 1,1584364 0,00119142 9,53E-06SMAD6 -0,4472466 0,61817366 0,2904102 0,5748161 1,27E-04 1,33E-06

Pöschl et al., Suppl. Table 3

Page 12: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

SMPDL3A -0,7160996 0,36907792 0,0721707 0,6410513 2,09E-04 1,99E-06SPHKAP -0,370404 0,50993276 1,958851 1,8665496 1,50E-04 1,51E-06SREBF2 -0,2874797 0,8118976 0,431087 0,77924067 0,02783053 1,72E-04

ST6GAL2 -0,4354087 0,3143439 0,4002094 0,83106667 0,0049151 3,36E-05STAC -0,3915585 0,54841083 0,5266845 0,75820273 2,79E-04 2,58E-06STX7 -0,4811688 0,6374237 0,4373166 0,68424505 4,47E-05 5,25E-07SV2B -0,6847444 0,43778887 0,0233998 0,7096411 0,00574526 3,88E-05

TEK -0,4974058 0,60711986 0,8078179 1,1936158 0,00144554 1,13E-05TIAM1 -0,364796 0,3008619 0,167677 0,4439039 3,24E-04 2,89E-06

TLE4 -0,0979121 0,6937363 0,930536 1,0090116 0,00456998 3,15E-05TMEFF2 -0,350781 0,51214564 0,61375 0,9981121 0,00876284 5,82E-05

TMEM178A -0,3585647 0,71416587 0,8374557 1,1928674 0,00516723 3,51E-05TMEM56 -0,5048593 0,43631238 0,658014 1,2581904 0,01482112 9,56E-05

TNFAIP8L1 0,3791382 0,8114021 1,3439624 1,115844 0,04141621 2,49E-04TRHDE -0,4823251 0,8035727 1,5071465 1,6624619 3,14E-04 2,83E-06

TRIB1 -0,0975314 0,7613297 0,758401 0,6514806 9,37E-05 1,02E-06UQCRC1 -0,6515997 0,76806855 0,626607 1,1492009 0,00114908 9,23E-06YWHAB -0,755172 0,72642666 0,2095014 0,9353588 0,00414306 2,91E-05

ZIC2 0,0836005 0,65579444 1,6489164 0,6640178 1,30E-11 1,64E-12ZNF385B -0,5625945 0,37702718 -0,2201105 0,3808711 0,03544933 2,16E-04

High in human adult SHH and murine tumors

 

MEAN ADULT and MOUSE

Tumors

SD Adult and Mouse Tumors

Mean Infant Tumors

SD Infant Tumors

adjusted p-value FDR

ACER3 -0,0952256 1,011967 -0,957838 0,2881769 2,26E-10 1,64E-11AHRR 0,5981068 1,301876 0,01778 0,3198872 0,012237 8,02E-05

ANXA4 1,0743653 1,147776 0,087374 0,8064941 7,02E-04 5,92E-06APOM 0,3689296 1,008735 -0,351325 0,4778444 1,14E-04 1,20E-06

B4GALT4 -0,0480345 0,862099 -0,692056 0,3516372 4,34E-06 6,94E-08BEND7 0,940102 0,987179 -0,158313 0,5720118 1,58E-08 5,83E-10

BTBD11 1,091316 1,087677 -0,186072 0,5610309 7,00E-11 6,42E-12C12ORF65 0,4213464 1,07523 -0,545668 0,5418081 5,98E-07 1,16E-08C16ORF46 0,2460915 1,068398 -0,384951 0,5302064 0,0082143 5,47E-05C1ORF114 -0,2054475 0,84276 -0,628757 0,336676 0,0192801 1,22E-04C7ORF60 1,2616937 1,522562 -0,021688 0,7246883 1,46E-06 2,58E-08CACHD1 0,0536923 0,675923 -0,610066 0,1646029 0 0

CAHM 0,2224798 1,283444 -0,447186 0,536771 0,014838 9,59E-05CASP9 0,2412068 1,060102 -0,603843 0,5640832 4,52E-05 5,26E-07

CCDC113 0,0394992 1,139139 -0,640771 0,4554429 8,85E-04 7,30E-06CCDC88C -0,0407081 0,755089 -0,381261 0,2450627 0,0299966 1,84E-04

CCND1 1,444437 1,441189 -0,165493 0,2953426 0 0CDC42EP4 0,7632887 1,376525 -0,191658 1,0041623 0,0354765 2,16E-04

CDK20 -0,2420426 0,865941 -1,143827 0,4614403 1,74E-08 6,04E-10CETN2 0,4130892 1,092342 -0,453519 0,7378797 0,0018049 1,37E-05

CHRDL2 0,2464835 1,087594 -0,514763 0,3935759 6,14E-06 9,47E-08CKLF-CMTM1,CKLF 0,966255 0,823168 0,06648 0,6129114 1,11E-05 1,59E-07

CNTN3 0,4688856 1,362617 -0,456466 0,1536363 3,15E-08 9,67E-10CYB561 -0,443189 0,314315 -0,653358 0,1088157 1,39E-05 1,91E-07

CYP3A7-CYP3AP1 0,5417137 1,435156 -0,224892 0,4778651 0,0019719 1,48E-05DYX1C1 0,4147727 0,904297 -0,543846 0,5212942 7,04E-08 1,81E-09

EBF4 -0,1104117 0,862199 -0,780001 0,4759495 1,46E-04 1,50E-06EFS 1,180655 0,886495 0,078557 0,8123115 4,26E-05 5,08E-07

EMILIN2 0,07424 0,908357 -0,446843 0,3805681 0,0029577 2,14E-05EXTL3 -0,0833707 0,854009 -0,64975 0,4650104 0,0029526 2,14E-05

FAIM 0,4182827 0,910899 -0,251506 0,4863372 3,02E-04 2,77E-06FAM76A 0,4394886 0,976084 -0,291399 0,7204956 0,0139394 9,05E-05

FANCL 0,7750043 0,829993 -0,306906 0,7590218 1,45E-05 1,97E-07FBXO46 0,5583004 0,970048 -0,254534 0,7480789 0,0042003 2,93E-05

FGD4 -0,0637363 1,218802 -0,906401 0,207153 3,80E-08 1,11E-09FKBP9 0,346961 0,90628 -0,293627 0,5616908 0,004404 3,06E-05

Pöschl et al., Suppl. Table 3

Page 13: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

FOXA2 0,3199777 0,971904 -0,357038 0,0280633 6,75E-09 3,15E-10FOXL2 0,4916586 1,435407 -0,21137 0,4931276 0,0114004 7,50E-05FOXQ1 0,0514593 0,889428 -0,313801 0,1387825 0,0172287 1,10E-04

GALNT1 0,458444 0,871609 -0,655611 0,6196032 4,94E-08 1,37E-09GAS2L1 -0,090239 0,957126 -0,88512 0,5374874 4,02E-05 4,88E-07

GCA 0,6086573 1,054532 -0,440584 0,5641242 8,64E-08 2,04E-09GCM1 0,5735888 1,279086 -0,50052 0,3112257 8,63E-11 6,72E-12

GGNBP2 -0,1151472 0,857138 -0,625835 0,4926461 0,0280362 1,73E-04GLIS2 0,9586489 1,139555 -0,520197 0,7917689 1,54E-08 5,89E-10

GMCL1 0,9196033 0,840332 0,262815 0,7240793 0,0415592 2,50E-04GPR85 1,4470918 1,123342 0,293114 0,8114678 2,60E-05 3,33E-07

GZF1 0,4602987 0,932817 -0,712238 0,7093162 4,69E-07 9,36E-09HOXA-AS4,MIR196B 0,6529936 1,474616 -0,416103 0,1998922 3,30E-09 1,77E-10

HOXA1 0,5031866 1,489294 -0,254 0,3981102 0,0015443 1,20E-05HOXA10 0,6317715 1,395936 -0,485327 0,0539474 1,87E-11 2,09E-12HOXA11 0,4322283 1,217073 -0,299653 0,2636619 9,90E-06 1,44E-07HOXA2 0,6660435 1,654942 -0,342502 0,0845849 8,07E-07 1,49E-08HOXA4 0,4752561 1,052226 -0,404863 0,1667724 8,41E-12 1,20E-12HOXC9 -0,1840945 0,490334 -0,510984 0,0361188 4,33E-08 1,23E-09HOXD3 -0,1827093 0,82528 -0,603989 0,0273359 1,10E-04 1,18E-06

HRASLS 0,0132176 0,82279 -0,618592 0,344511 2,82E-06 4,77E-08HSD11B2 1,4870064 1,158759 0,147834 0,6686629 3,91E-09 2,00E-10

HUNK -0,312809 0,633394 -0,599929 0,2046803 0,0275728 1,71E-04IFI27L2 -0,0739198 0,795994 -0,724342 0,4053974 1,15E-05 1,62E-07

IFT81 0,559194 1,023085 -0,506067 0,6280697 5,37E-07 1,05E-08KAT6B 0,9563817 1,480377 -0,054822 0,697697 2,91E-04 2,68E-06

KDM3A 0,7376887 0,761071 -0,424122 0,6990894 3,30E-07 6,82E-09KIAA1143 0,798632 0,994803 -0,069972 0,741492 0,0012959 1,03E-05L3MBTL3 0,2847604 0,937449 -0,752137 0,4468039 8,63E-11 7,26E-12

LAP3 1,1864674 1,02953 0,306468 0,8953609 0,0145491 9,43E-05LASP1 -0,1750205 0,859123 -1,054654 0,4440873 1,50E-08 5,95E-10

LCA5 0,8974945 1,075549 0,053365 0,6596208 5,60E-04 4,84E-06LDB3 0,2654933 1,255933 -0,263936 0,3379459 0,0377066 2,28E-04LHX2 0,0546727 0,692179 -0,765533 0,0968611 0 0

LOC100506963 0,4510414 0,960752 -0,508895 0,7118466 8,15E-05 9,10E-07LOC729059 0,262781 1,154645 -0,447227 0,652477 0,0153043 9,86E-05

LRRC8D 0,416706 0,868314 -0,34169 0,3862729 1,31E-07 2,86E-09LUC7L2 0,5303025 0,858776 -0,21047 0,767474 0,0175491 1,12E-04

MAP3K1 1,1092884 1,056861 -0,143627 0,6665403 1,86E-08 6,06E-10MAP3K7 0,6546888 0,797773 -0,208613 0,7853407 0,0019782 1,48E-05MARC1 0,3777475 1,154243 -0,361283 0,7110641 0,0194348 1,23E-04MDFIC 1,134877 1,248855 0,130066 0,5289025 7,95E-07 1,49E-08

NFATC1 0,8949742 0,989438 0,000715 0,7166965 4,28E-04 3,80E-06NHLRC2 0,6292607 0,902075 -0,490868 0,844819 6,26E-05 7,10E-07

NKAP 0,3475758 0,88059 -0,299814 0,5658765 0,0035399 2,52E-05NKX2-5 0,3983375 1,245536 -0,37102 0,244548 2,99E-06 4,91E-08NKX3-2 0,3186125 0,967768 -0,514778 0,4084792 7,93E-08 1,95E-09

NT5DC1 0,9685275 1,167992 0,150787 0,6487275 0,0013835 1,09E-05NUCB2 0,0755247 0,704866 -0,576815 0,3748322 7,65E-07 1,45E-08

OCRL -0,073078 0,893888 -0,735896 0,5433634 0,0014771 1,15E-05ONECUT1 0,6343161 1,597973 -0,21901 0,5070946 0,0014677 1,15E-05

OTX2 -0,2795478 1,105154 -1,13197 0,1635387 2,97E-10 2,01E-11PAN2 0,3823816 0,870212 -0,750166 0,5969486 1,07E-08 4,42E-10

PARD3 0,5063717 0,986804 -0,638582 0,5318242 4,45E-10 2,83E-11PAX5 -0,0346022 1,230216 -0,688136 0,0551955 4,25E-05 5,11E-07

PCDHB10,PCDHB9 0,0600051 0,875091 -0,630943 0,5338054 4,63E-04 4,04E-06PCDHB14 0,2034172 0,933378 -0,591328 0,3825078 6,76E-08 1,78E-09

PCGF5 0,6710183 0,992894 0,040571 0,4385573 6,72E-04 5,72E-06PDCD7 0,3367924 0,946307 -0,444676 0,7084231 0,0035663 2,53E-05PDE6B 0,021451 0,692546 -0,346484 0,1973341 8,65E-04 7,17E-06

PDLIM4 -0,1222025 0,77563 -0,438341 0,1342339 0,0224325 1,41E-04PHACTR1 -0,178674 0,557283 -0,619847 0,3066461 9,04E-05 9,87E-07

Page 14: Pöschl et al., Suppl. Material Supplementary Material: Suppl. Figure 1: Related to Figure 1. Details on the 423 analyzed human medulloblastoma samples

PHF17 -0,2005346 0,644414 -0,812363 0,4542049 9,56E-05 1,03E-06PHF19 0,2867364 0,86474 -0,364907 0,5422755 0,001668 1,28E-05PITX2 0,5171804 1,048851 -0,203359 0,4724459 1,47E-04 1,49E-06POLI 0,5635464 1,120879 -0,229633 0,653977 0,0020855 1,55E-05

POU4F2 -0,1072643 0,826568 -0,485153 0,1151774 0,0022891 1,69E-05PPCDC 0,245646 0,943732 -0,326455 0,5720534 0,0355465 2,16E-04

PUS7 0,4065213 0,869527 -0,231145 0,4452824 1,81E-04 1,77E-06RAD17 0,4818599 0,978546 -0,385033 0,9084581 0,0188629 1,20E-04

RALGPS2 0,2077333 0,962697 -0,368668 0,1942998 8,47E-06 1,29E-07RB1 1,0337054 0,976938 -0,062008 0,8505462 1,38E-04 1,44E-06

RBL2 0,2968916 0,905773 -0,325189 0,6432979 0,03066 1,88E-04RECQL 0,756507 1,110898 -0,223905 0,4834452 5,93E-08 1,60E-09RGAG4 0,2343118 0,940985 -0,441194 0,5671903 0,0024196 1,77E-05RIBC1 0,3001196 0,956242 -0,582118 0,7369257 7,82E-04 6,51E-06

RSRC1 0,4586014 0,775147 -0,25497 0,3188119 4,12E-09 2,01E-10RYK 0,8500287 0,839955 -0,131344 0,6937516 1,94E-05 2,62E-07

SIPA1L3 0,693761 0,931099 -0,361994 0,8754551 4,33E-04 3,82E-06SLC10A4 -0,2489188 0,74363 -0,754792 0,1273946 7,09E-08 1,79E-09

SLC26A11 -0,5622037 0,46589 -1,14466 0,2840126 1,21E-09 6,88E-11SMAD5 0,1673476 0,894725 -0,580813 0,5322102 8,87E-05 9,76E-07

SNX7 1,1021063 1,16926 0,219546 0,61549 1,40E-04 1,45E-06STK32C 0,2528254 1,083473 -0,815711 0,5347794 1,83E-08 6,14E-10STXBP3 0,2013184 1,240376 -0,448863 0,583995 0,0323643 1,98E-04

SWI5 -0,203258 0,753479 -0,753938 0,2661984 1,21E-06 2,19E-08TBX1 0,5090353 0,853923 -0,291625 0,6176972 1,99E-04 1,92E-06

THNSL1 0,700196 0,901092 -0,183279 0,8908826 0,0097308 6,43E-05TIPIN 0,8037402 0,795967 -0,5242 0,6029882 6,04E-11 6,08E-12

TMEM107 0,6419439 0,958967 -0,320631 0,5226639 1,01E-07 2,34E-09TMEM164 -0,1988593 0,84078 -0,561389 0,2569161 0,0431573 2,58E-04TMEM45A 0,1663927 0,891957 -0,306112 0,234917 6,11E-04 5,23E-06

TSHZ3 0,3707785 0,863036 -0,716207 0,0795852 0 0TSPAN14 0,7810885 1,194303 0,054398 0,753192 0,0477096 2,85E-04

TYW1B,TYW1 0,206088 0,984801 -0,845668 0,5542871 2,87E-08 9,08E-10UBE4A 0,2477583 1,118411 -0,748115 0,5036421 8,51E-08 2,05E-09

UNG 0,694907 0,867657 -0,354629 0,7172118 8,73E-06 1,31E-07VAMP7 0,0245935 0,772734 -0,65886 0,5769031 0,0010469 8,52E-06VGLL4 0,6344673 0,867071 -0,253393 0,7151102 3,13E-04 2,83E-06VWCE 0,5820996 1,331485 -0,155876 0,5453785 0,0045238 3,13E-05

WDR5B 0,3523528 1,225702 -0,632634 0,6838791 7,87E-05 8,86E-07WDSUB1 -0,0437685 1,027241 -0,662819 0,6388025 0,0476504 2,84E-04ZBTB20 0,8710315 1,050409 -0,348773 0,5744141 6,37E-10 3,81E-11ZCRB1 0,6153397 1,022732 -0,232889 0,6872098 7,20E-04 6,05E-06

ZKSCAN4 0,7067904 0,861156 -0,064777 0,65329 0,0010527 8,53E-06ZMYM2 0,22118 0,947893 -0,497022 0,7597044 0,029507 1,82E-04ZNF25 0,9285087 1,056975 -0,244179 0,7515834 2,75E-06 4,70E-08

ZNF274 0,3112697 0,844664 -0,679546 0,6308789 1,96E-06 3,40E-08ZNF397 0,0445938 0,872268 -0,645448 0,2904636 3,67E-08 1,10E-09ZNF438 0,703916 0,840858 -0,479737 0,874898 3,86E-05 4,77E-07ZNF503 0,4975666 0,884572 -0,350168 0,1825055 0 0

ZNF664-FAM101A,FAM101A -0,0140498 1,03962 -0,576498 0,1826772 8,49E-05 9,41E-07

Pöschl et al., Suppl. Table 3

Suppl. Table 3: 287 genes that are similarly expressed in adult human SHH medulloblastoma and murine Shh medulloblastoma mouse models and significantly differ from infantile human SHH medulloblastoma.